Clinical Trial Update: Propranolol Reactivation Mismatch (PRM) Treatment for PTSD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on propranolol reactivation mismatch (PRM) treatment for post-traumatic stress disorders is reported with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• propranolol reactivation mismatch (PRM) treatment (propranolol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Stress Disorders, Post-Traumatic | Phase 4 | Status: UNKNOWN